Celldex Therapeutics Inc. (CLDX)

Countries with the Smallest Government Per Capita in the World

Hedge Fund and Insider Trading News: King Street Capital, Third Point LLC, Alta Mesa Resources Inc (AMR), HubSpot Inc (HUBS), MYnd Analytics Inc (MYND), and More

U.S. Hedge Fund Seeks Board Shake-Up at Toshiba (The Wall Street Journal) TOKYO—New York-based hedge fund King Street Capital Management LP has proposed......(read more)

August 31 - Hedge Funds, Insider Trading - Comments

test, cancer, researcher, research, dna, bio, clean, modern, chemistry, human, white, medical, sample, pipette, life, culture, laboratory, biotechnology, genetic, disease,

Three Cancer Plays For The Fourth Quarter Of 2016

We are now into the final quarter of 2016, and there looks set to be plenty of activity across the biotech space before the year draws to a close. Companies......(read more)

October 5 - News - Comments

stock, graph, low, crash, down, arrow, risk, fall, crack, price, bad, market, debt, statistics, sales, economy, decline, failure, red, loss, business, concept, diagram, rates,

Hedge Funds Wisely Fled These Tanking Stocks

The importance of hedge fund sentiment is not only reflected by the long positions that these firms take in high flying companies, but also how quickly......(read more)

May 8 - Hedge Funds, News - Comments

Dendreon Corporation (DNDN), Celldex Therapeutics, Inc. (CLDX): Is There Still Upside in Immunotherapy?

Three years ago, cancer immunotherapy was the hottest thing in biotech, as Dendreon Corporation (NASDAQ:DNDN)‘s Provenge earned approval from the......(read more)

September 12 - News - Comments

Hedge Funds Are Betting On Celldex Therapeutics, Inc. (CLDX)

If you were to ask many market players, hedge funds are assumed to be overrated, old investment vehicles of a forgotten age. Although there are more than......(read more)

September 4 - News - Comments

Here is What Hedge Funds and Insiders Think About Puma Biotechnology Inc (PBYI)

What’s a smart Puma Biotechnology Inc (NYSE:PBYI) investor to do? In today’s marketplace, there are dozens of methods market participants can......(read more)

September 3 - News - Comments

Celldex Therapeutics, Inc. (CLDX), Dendreon Corporation (DNDN): Why Wall Street Has Turned Against It

Since Dendreon Corporation (NASDAQ:DNDN) reported its second-quarter earnings, the stock has declined 40%. Following the quarter, analysts from Wedbush......(read more)

August 28 - News - Comments

NPS Pharmaceuticals, Inc. (NPSP): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?

In today’s marketplace, there are tons of gauges market participants can use to track their holdings. A duo of the most innovative are hedge fund and......(read more)

August 28 - News - Comments

This MannKind Corporation (MNKD) Data Is Simply Jaw-Dropping. Wow.

MannKind Corporation (NASDAQ:MNKD) has gotten one of the biggest votes of confidence we’ve seen from the smart money, out of the entire stock market......(read more)

August 22 - News - Comments

Seattle Genetics, Inc. (SGEN), Celldex Therapeutics, Inc. (CLDX): This Company Has Potential to Grow

Cancer is the target of a number of different biotech companies. Out of this lot, I consider Seattle Genetics, Inc. (NASDAQ:SGEN) to be one of the star......(read more)

August 6 - News - Comments

Keryx Biopharmaceuticals (KERX): Rare Diseases and Rare Drugs Could Mean Great Gains For You

The U.S. is the largest market of biotechnology products in the world. There are more than 1,300 companies involved in the research and development of......(read more)

July 18 - News - Comments

Celldex Therapeutics, Inc. (CLDX): 4 Reasons This Biotech Went up by 400 Percent

Celldex Therapeutics, Inc. (NASDAQ:CLDX), the first antibody-based immunotherapy company, has been a strong buy recommended by several analysts for some......(read more)

July 17 - News - Comments

ACADIA Pharmaceuticals Inc. (ACAD), Alnylam Pharmaceuticals, Inc. (ALNY) & Celldex Therapeutics, Inc. (CLDX): Buy These Biotech Companies for Long-Term Growth

According to IBISWorld, revenue of global biotechnology companies will surge to $262 billion this year, up by 12.7%, year-over-year. This growth is due......(read more)

July 16 - News - Comments

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Alnylam Pharmaceuticals, Inc. (ALNY)’s Surge Caps Off a Strong Week in Biotech

Biotech’s the biggest boom-or-bust business on the market, with regulatory approvals and clinical trial results routinely sending stocks hurtling......(read more)

July 15 - News - Comments

Celldex Therapeutics, Inc. (CLDX), Cytokinetics, Inc. (CYTK): Are These Top Biotech Performers Still Worth Buying?

Only a handful of stocks have gained 200% in 2013, and five of those stocks are in the biotechnology industry. Perhaps you already own one, or maybe......(read more)

July 12 - News - Comments

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Onyx Pharmaceuticals, Inc. (ONXX), Celldex Therapeutics, Inc. (CLDX): Three Humongous Health-Care Stocks This Week

While many American skies were lit up with fireworks this week, the stock market also saw its share of pops, sizzles, and bangs. Here are three health......(read more)

July 8 - News - Comments

Celldex Therapeutics, Inc. (CLDX) On The Rise

There are many biotech stocks that target cancer, but what is good about Celldex Therapeutics, Inc. (NASDAQ:CLDX) is that it is targeting many therapeutic......(read more)

July 3 - News - Comments

Celldex Therapeutics, Inc. (CLDX), ACADIA Pharmaceuticals Inc. (ACAD): Two Biotech Stocks That Could Soon be Acquired

While a company is in the clinical phase of development, there are roughly four catalysts that could move the stock higher. 1. Expansion of intellectual......(read more)

July 1 - News - Comments

Celldex Therapeutics, Inc. (CLDX), Galena Biopharma Inc (GALE): Good And Bad Breast Cancer Drugs

With more than 230,000 women diagnosed with breast cancer in the U.S. annually – and Roche’s Herceptin producing annual sales of more than $5 billion......(read more)

June 17 - News - Comments

ImmunoGen, Inc. (IMGN), Seattle Genetics, Inc. (SGEN), Celldex Therapeutics, Inc. (CLDX): A Trio of Cancer Immunotherapy Innovators

The cancer world has been abuzz after an exciting ASCO conference. Bristol Myers Squibb Co. (NYSE:BMY) presented really promising updates for its PD-......(read more)

June 14 - News - Comments

Dendreon Corporation (DNDN), Celldex Therapeutics, Inc. (CLDX): A Promising Platform for Cancer Immunotherapy

A 2011 Nobel Prize in Physiology and Medicine is certainly impressive. Using a novel cancer treatment on yourself is both impressive and courageous. ......(read more)

June 10 - News - Comments

Here is What Hedge Funds Think About Puma Biotechnology Inc (PBYI)

Is Puma Biotechnology Inc (NYSE:PBYI) a buy here? Hedge funds are betting on the stock. The number of bullish hedge fund bets improved by 2 lately. In......(read more)

June 10 - News - Comments

Ariad Pharmaceuticals, Inc. (ARIA) Among The Biotech Players To Watch

Three biotech companies are making themselves heard in the stock market. They are making a mark in the life sciences space with their unique mix of science......(read more)

May 1 - News - Comments

Puma Biotechnology Inc (PBYI), Achillion Pharmaceuticals, Inc. (ACHN): Here is What Hedge Funds Think About NPS Pharmaceuticals, Inc. (NPSP)

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) has seen a decrease in enthusiasm from smart money in recent months. According to most investors, hedge funds......(read more)

April 8 - News - Comments

Posts Tagged ‘Celldex Therapeutics Inc. (CLDX)’